Cholinergic urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
4
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
cerebellar function
|
disease |
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Medullary carcinoma of breast
|
disease |
|
Neoplastic Process
|
15
|
2
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cannabis Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
40
|
13
|
0.020 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
Orofacial Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
40
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fetal Alcohol Spectrum Disorders
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders
|
Disease or Syndrome; Congenital Abnormality
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Bilirubin measurement
|
phenotype |
|
Laboratory Procedure
|
56
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Prostate Cancer, Hereditary, 7
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
59
|
11
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Post-Traumatic Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
61
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
HIV-associated neurocognitive disorder
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
61
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cancer Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
62
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic interstitial cystitis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
64
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Osteoporosis, Senile
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
73
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Cannabis use
|
disease |
|
Mental or Behavioral Dysfunction
|
74
|
44
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Osteoporosis, Age-Related
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
89
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Varicocele
|
disease |
Male Urogenital Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
99
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenosquamous carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
101
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pain, Postoperative
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
102
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Interstitial Cystitis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
122
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant Bone Neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
125
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cholesteatoma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
135
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Gastric ulcer
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
136
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Enzyme inhibition disorder
|
phenotype |
|
Disease or Syndrome
|
171
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |